This explains our no show at the MASH conference. It was not the imaginary NDAs, but the “not significant results” on steatosis. Occam rules.
(10)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.